Ipsen (France)

Recent papers from Ipsen (France)

1. Summary of Research: Health-Related Quality-of-Life Profile and Clinical Outcomes in First-Line Advanced Renal Cell Carcinoma: A Modeling Analysis Based on the CheckMate 9ER StudyAdvances in Therapy · 2026
2. Summary of Research: Two-Stage Estimation of Overall Survival in the Phase 3 CheckMate 9ER Trial, Adjusting for the Impact of Subsequent TherapyAdvances in Therapy · 2026
3. Clinical efficacy/effectiveness, safety, and health-related quality of life associated with relapsed/refractory pediatric low-grade glioma treatments: systematic literature reviewNeuro-Oncology Pediatrics · 2026
4. Indirect treatment comparison of odevixibat and maralixibat for the treatment of cholestatic pruritus in patients with Alagille syndromeJournal of Comparative Effectiveness Research · 2026
5. Palovarotene Impact on Fibrodysplasia Ossificans Progressiva (FOP): Data from Month 48 of the Phase 3 MOVE TrialJBMR Plus · 2026
6. Mapping structural heterogeneity in three-dimensional biophotonic gyroid networks using position-resolved small-angle X-ray scatteringInterface Focus · 2026
7. Real-world treatment patterns and clinical outcomes of patients with primary biliary cholangitis in the United StatesJournal of Comparative Effectiveness Research · 2026
8. Burden of fatigue or pruritus in patients with primary biliary cholangitis: a United States matched case-control study.2026
9. Elafibranor in primary biliary cholangitis: two-year placebo-controlled outcomes and long-term open-label data from the ELATIVE® phase III trialJournal of Hepatology · 2026
10. Berotralstat Tolerability and Effectiveness in Hereditary Angioedema: Berolife Study ResultsClinical and Translational Allergy · 2026
11. Quantitative Hyperspectral Luminescence Imaging Reveals Upscaling Losses in Perovskite Solar ModulesSolar RRL · 2026
12. Development of the Fibrodysplasia Ossificans Progressiva FLare EXperience Revised (FOP-FLEX-R©) Questionnaire: A Patient-Reported Outcome MeasureBone · 2026
13. Regional Differences in Use of Injection Guidance and Goal Attainment Following Repeat AbobotulinumtoxinA Injections: Subgroup Analysis of the AboLiSh Observational Study (P5-14.004)Neurology · 2026
14. Сопоставительный Анализ Дообучения Мультиязычных Нейросетевых Моделей Машинного Перевода Для Узбекско-Русской Языковой ПарыSCIENCE TIME · 2026
15. Cultural Capital Skill Development in Undergraduate Kinesiology Curriculum2025
16. Metabolic Effects of R-1,3-Butanediol (Ketone-Iq) During Aerobic and Anaerobic Exercise Bouts2025
17. Incidence, severity, and management of severe adverse events in first-line (1L) treatments for metastatic pancreatic ductal adenocarcinoma (mPDAC): A retrospective observational study.Journal of Clinical Oncology · 2026
18. Real‐World Patterns of Botulinum Toxin Treatment in Hyperkinetic Movement Disorders: A 9‐Year Nationwide Analysis in FranceMovement Disorders Clinical Practice · 2026
19. A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb SpasticityAdvances in Therapy · 2026
20. Abstract ND12: Development of IPN01203, a dual T cell agonist activating Vβ6/Vβ10 TCR-expressing T cellsCancer Research · 2026